Market revenue in 2023 | USD 2.4 million |
Market revenue in 2030 | USD 4.2 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 54.17% in 2023. Horizon Databook has segmented the Kuwait mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The growing interest in R&D activities, the aging population, and high per capita income contributed to an increase in the total demand for biopharmaceuticals and biotechnology products in Kuwait. Furthermore, Kuwait's growing population and evolving healthcare needs created a demand for advanced medical technologies, including cell culture techniques wherein mycoplasma testing is used widely.
The country is focused on improving its healthcare infrastructure and services, contributing to market growth. In addition, there is a rise in the prevalence of chronic diseases, such as CVDs, cancer, and autoimmune disorders, in Kuwait. To diagnose, treat, and research such diseases, cell culture techniques are crucial. As a result, the demand for mycoplasma testing in the country is expected to rise significantly.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account